HONG KONG and BOSTON, May 4 (Bernama-GLOBE NEWSWIRE) — Zenas BioPharma (“Zenas”), a cross-border (China-USA based) biopharmaceutical company committed to the development and delivery of immune-based therapies, today announced the appointment of Hua Mu, MD, Ph.D. as President and Chief Executive Officer and Acting Chief Medical Officer and Joe Farmer as Chief Business and Administrative Officer.
“We are delighted to have Hua join the Zenas executive leadership team,” said Lonnie Moulder, Founder and Executive Chairman. “His extensive experience, including building and leading R&D organizations in China, and his track record of successful development and approval of new drugs in the US and China will be critical as Zenas builds a global organization and advances its innovative pipeline of immune-based therapies.”